the flipi24 model for identifying poor outcomes in non-immunochemotherapy treated fl
Published 10 months ago • 67 plays • Length 6:05Download video MP4
Download video MP3
Similar videos
-
2:55
a model including cd49d expression to predict outcomes in patients with cll treated with ibrutinib
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
5:55
validation of non-invasive ai diagnostic tool for mds
-
1:40
challenges and options for patients with hydroxyurea-resistant pv
-
3:10
the potential for early identification of relapse in dlbcl using serial ctdna sampling
-
1:49
genomic advancements in non-malignant hematology
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
6:40
fc120 pure kit components and hemoconcentrator only components and processing guide
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
3:29
ptcy as gvhd prophylaxis: side effects, optimizing the dose, and the effect of dose-reduction
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:56
choose your visualization in oncological reconstructive surgery
-
3:19
supportive care in al amyloidosis
-
3:02
euplagia-1: phase i trial of glpg5201, a cd19 car-t product, in r/r cll and richter's transformation
-
1:47
shared treatment decision-making
-
2:12
barriers to the implementation and standardization of ai in the clinic
-
1:14
the possible applications of ai models in surgical oncology
-
1:19
al amyloidosis: mrd negativity
-
8:34
hct in mds: cell source and conditioning type